Wei-I Chou

Title: Innovations and Contributions of Inventor Wei-I Chou

Introduction

Wei-I Chou is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the field of biotechnology, particularly in the development of vaccine technologies. With a total of four patents to his name, his work has had a substantial impact on immunology and vaccine development.

Latest Patents

Wei-I Chou's latest patents include innovative technologies such as baculovirus display vectors and their applications. This patent discloses a recombinant baculovirus that displays a fusion protein on its envelope. The fusion protein consists of a heterologous antigen and a C-terminal region of the baculovirus envelope GP64 protein. The genome of this recombinant baculovirus includes a transgene that encodes a fusion protein designed to elicit an antigen-specific immunogenic response. Another notable patent involves vaccine compositions targeting porcine reproductive and respiratory syndrome and porcine circovirus-associated diseases. This patent describes a fusion protein that comprises various antigens and is useful for inducing both cell-mediated and humoral immune responses.

Career Highlights

Throughout his career, Wei-I Chou has worked with several companies, including Reber Genetics Co., Ltd. and Thevax Genetics Vaccine Co., Ltd. His expertise in vaccine development has positioned him as a key figure in the biotechnology sector.

Collaborations

Wei-I Chou has collaborated with notable individuals in his field, including Hsiu-Kang Chang and Chia-Mao Wu. These collaborations have further enhanced his research and contributions to vaccine technology.

Conclusion

Wei-I Chou's innovative work in biotechnology and vaccine development has made a significant impact on the field. His patents reflect his commitment to advancing immunological research and improving public health through effective vaccine solutions.